NFKB1 and obesity disorder: Endogenous lipid interaction with cannabinoid receptors (CB1 and CB2) activates adenylate cyclase and also promotes secondary messengers implicated in the MAPK, ERK, and NF-κB pathways, causing inflammation and insulin resistance and eventually contributing to obesity.